Safety of mirtazapine: A review

International Clinical Psychopharmacology

Volumn 10, Issue , 1995, Pages 37-45

  Montgomery, S A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressants; Mirtazapine; Safety

Indexed keywords

AMITRIPTYLINE; MIRTAZAPINE;

ADULT; APPETITE; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DROWSINESS; DRUG SAFETY; FEMALE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEDATION; SIDE EFFECT;

ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; OVERDOSE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0029586363     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199512004-00006     Document Type: Article

References (28)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. American Psychiatric Association, Washington DC.
2. Bremner JD (1995) A double-blind comparison of Org3770, amitriptyline and placebo in major depression. Journal of Clinical Psychiatry, 56, 519–526.
3. Claghorn JL and Lessem M (1995) A double-blind placebo- controlled study of Org3770 in depressed outpatients. Journal of Affective Disorders, 34, 165–171.
4. de Boer T and Ruigt GSF (1995) The selective a2-an- tagonist mirtazapine (Org3770) enhances noradrenergic and serotonin1A-mediated serotonergic neurotransmission. Central Nervous System Drugs, 4 (suppl 1), 29–38.
5. de Boer T, Maura G, Raiteri M, de Vos CJ, Wieringa J and Pinder RM (1988) Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology, 27, 399–408.
6. de Boer T, Nefkens F and Van Helvoirt A (1994) The α2 adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. European Journal of Pharmacology, 253, R5–R6.
7. de Boer T, Ruigt GSF and Berendsen HHG (1995) The α2-selective adrenoreceptor antagonist Org 3770 (Mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Human Psychopharmacology, 10 (suppl 2), S107–S119.
8. de Montigny C, Haddjeri N, Mongeau R and Blier P (1995) The effects of mirtazapine on interactions between central noradrenergic and serotonergic systems. Central Nervous System Drugs, 4 (suppl 1), 13–17.
9. Arky R (ed) (1995) Physician’s Desk Reference, 49th edition. Medical Economics Data Production Company, Montvale, New Jersey.
10. Halikas JA (1995) Org 3770 (mirtazapine) versus trazodone: a placebo controlled trial in depressed elderly patients. Human Psychopharmacology, 10 (suppl 2), S125–S135.
11. Hamilton M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
12. Henry JA and Antao CA (1992) Suicide and fatal antidepressant poisoning. European Journal of Medicine 1, 343–348.
13. Hoes MJAJM and Zijpveld JHB (1996) First report of mirtazapine overdose. International Clinical Psychopharmacology, 10, in press.
14. Høyberg OJ, Maragakis B, Mullin J et al. (1996) A double blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychi- atrica Scandinavica, in press.
15. Mann JJ and Kapur S (1991) The emergence of suicidal ideation and behaviour during antidepressant pharmacotherapy. Archives of General Psychiatry, 48, 1027–1033.
16. Marttila M, Jaaskelainen J, Jarvi R et al. (1995) A double-blind study comparing the efficacy and tolerability of Org 3770 and doxepin in patients with major depression. European Neuropsychopharmacology, 15, 441–446.
17. Montgomery SA and Pinder RM (1987) Do some antidepressants promote suicide? Psychopharmacology, 92, 265–266.
18. Mullin J, Lodge A, Bennie E, McCreadie R, Bhatt GS and Fenton G (submitted) A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression.
19. Richou H, Ruimy P, Charbaut J et al. (1995) A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3770. Human Psychopharmacology, 10, 263–271.
20. Rosenstein DL, Nelson JC and Jacobs SC (1993) Seizures associated with antidepressants: a review. Journal of Clinical Psychiatry, 54, 289–299.
21. Sitsen JMA and Zivkov M (1995) Mirtazapine: clinical profile. Central Nervous System Drugs, 4 (suppl 1), 39–48.
22. Sitsen AMJ, Zivkov M and Dieterle D (1995) Wirksamkeit und Veträglichkeit von Org 3770 bei Patienten mit einer Major Depression. Eine vergleichende Studie gegen Amitriptyline und Plazebo. Psychopharmakotherapie, 2, 68–71.
23. Timmer CJ, Lohmann AAM and Mink CPA (1995) Pharmacokinetic dose-proportionality study at steady state of mirtazapine from Remeron tablets. Human Psychopharmacology, 10 (suppl 2), S97-S107.
24. van Moffaert M, de Wilde J, Vereecken A et al. (1995) Mirtazapine is more effective than trazodone: a controlled study in hospitalised patients with major depression. International Clinical Psychopharmacology, 10, 3–11.
25. Voortman G and Paanakker JE (1995) Bioavailability of mirtazapine from Remeron tablets after single and multiple oral dosing. Human Psychopharmacology, 10 (suppl 2), S83–S97.
26. World Health Organisation (1989) Adverse Reactions Terminology. Geneva, WHO.
27. Zivkov M and de Jongh GD (1995) Org 3770 vs amitriptyline: a 6-week randomised double-blind multicentre trial in hospitalised patients. Human Psychopharmacology, 10, 173-180.
28. Zivkov M, Roes KCB and Pols AG (1995) Efficacy of Org 3770 and amitriptyline in patients with major depressive disorder: a meta-analysis. Human Psychopharmacology, 10 (suppl 2), S135–S145.